Tennis elbow indication sought for OssaTron:
This article was originally published in Clinica
Executive Summary
HealthTronics Surgical Services has move to expand the US market for its shock wave device by submitting a premarket approval application to the FDA to use the product as a treatment for tennis elbow. The OssaTron device uses high-energy shock waves to cause microscopic damage to the scar tissue that forms in the elbow as a result of the condition. The therapy leads to the growth of new blood vessels in the area and allows tissue-healing cells to repair the chronic injury, says the Marietta, Georgia firm, which sells the device in the US for treating plantar fasciitis.